Antinociceptive effect of purine nucleotides. 1996

C F Mello, and J Begnini, and D D De-La-Vega, and F P Lopes, and C C Schwartz, and R E Jimenez-Bernal, and R G Bellot, and R Frussa-Filho
Departamento de QuĂ­mica, Universidade Federal de Santa Maria, Brasil. cfmello@super.ufsm.br

The antinociceptive effect of purine nucleotides administered systematically (sc) was determined using the formalin and writhing tests in adult male albino mice. The mechanisms underlying nucleotide-induced antinociception were investigated by preinjecting the animals (sc) with specific antagonists for opioid (naloxone, 1 mg/kg), purinergic P1 (caffeine, 5, 10, of 30 mg/kg); theophylline, 10 mg/kg) or purinergic P2 receptors (suramin, 100 mg/kg; Coomassie blue, 30-300 mg/kg; quinidine, 10 mg/kg). Adenosine, adenosine monophosphate (AMP), diphosphate (ADP) and triphosphate (ATP) caused a reduction in the number of writhes and in the time of licking the formalin-injected paw. Naloxone had no effect on adenosine- or adenine nucleotide-induced antinociception. Caffeine (30 mg/kg) and theophylline (10 mg/kg) reversed the antinociceptive action of adenosine and adenine nucleotide derivatives in both tests. P2 antagonists did not reverse adenine nucleotide-induced antinociception. These results suggest that antinociceptive effect of adenine nucleotides is mediated by adenosine.

UI MeSH Term Description Entries
D008297 Male Males
D009270 Naloxone A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors. MRZ 2593-Br,MRZ-2593,Nalone,Naloxon Curamed,Naloxon-Ratiopharm,Naloxone Abello,Naloxone Hydrobromide,Naloxone Hydrochloride,Naloxone Hydrochloride Dihydride,Naloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Narcan,Narcanti,Abello, Naloxone,Curamed, Naloxon,Dihydride, Naloxone Hydrochloride,Hydrobromide, Naloxone,Hydrochloride Dihydride, Naloxone,Hydrochloride, Naloxone,MRZ 2593,MRZ 2593 Br,MRZ 2593Br,MRZ2593,Naloxon Ratiopharm
D009292 Narcotic Antagonists Agents inhibiting the effect of narcotics on the central nervous system. Competitive Opioid Antagonist,Narcotic Antagonist,Opioid Antagonist,Opioid Antagonists,Opioid Receptor Antagonist,Opioid Reversal Agent,Competitive Opioid Antagonists,Opioid Receptor Antagonists,Opioid Reversal Agents,Agent, Opioid Reversal,Agents, Opioid Reversal,Antagonist, Competitive Opioid,Antagonist, Narcotic,Antagonist, Opioid,Antagonist, Opioid Receptor,Antagonists, Competitive Opioid,Antagonists, Narcotic,Antagonists, Opioid,Antagonists, Opioid Receptor,Opioid Antagonist, Competitive,Opioid Antagonists, Competitive,Receptor Antagonist, Opioid,Receptor Antagonists, Opioid,Reversal Agent, Opioid,Reversal Agents, Opioid
D009619 Nociceptors Peripheral AFFERENT NEURONS which are sensitive to injuries or pain, usually caused by extreme thermal exposures, mechanical forces, or other noxious stimuli. Their cell bodies reside in the DORSAL ROOT GANGLIA. Their peripheral terminals (NERVE ENDINGS) innervate target tissues and transduce noxious stimuli via axons to the CENTRAL NERVOUS SYSTEM. Pain Receptors,Receptors, Pain,Nociceptive Neurons,Neuron, Nociceptive,Neurons, Nociceptive,Nociceptive Neuron,Nociceptor,Pain Receptor
D011685 Purine Nucleotides Purines attached to a RIBOSE and a phosphate that can polymerize to form DNA and RNA. Nucleotides, Purine
D011802 Quinidine An optical isomer of quinine, extracted from the bark of the CHINCHONA tree and similar plant species. This alkaloid dampens the excitability of cardiac and skeletal muscles by blocking sodium and potassium currents across cellular membranes. It prolongs cellular ACTION POTENTIALS, and decreases automaticity. Quinidine also blocks muscarinic and alpha-adrenergic neurotransmission. Adaquin,Apo-Quinidine,Chinidin,Quincardine,Quinidex,Quinidine Sulfate,Quinora,Apo Quinidine,Sulfate, Quinidine
D002110 Caffeine A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling. 1,3,7-Trimethylxanthine,Caffedrine,Coffeinum N,Coffeinum Purrum,Dexitac,Durvitan,No Doz,Percoffedrinol N,Percutaféine,Quick-Pep,Vivarin,Quick Pep,QuickPep
D000700 Analgesics Compounds capable of relieving pain without the loss of CONSCIOUSNESS. Analgesic,Anodynes,Antinociceptive Agents,Analgesic Agents,Analgesic Drugs,Agents, Analgesic,Agents, Antinociceptive,Drugs, Analgesic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012394 Rosaniline Dyes Compounds that contain the triphenylmethane aniline structure found in rosaniline. Many of them have a characteristic magenta color and are used as COLORING AGENTS. Fuchsins,Magentas,Fuchsin,Triphenylmethane Aniline Compounds,Aniline Compounds, Triphenylmethane,Compounds, Triphenylmethane Aniline,Dyes, Rosaniline

Related Publications

C F Mello, and J Begnini, and D D De-La-Vega, and F P Lopes, and C C Schwartz, and R E Jimenez-Bernal, and R G Bellot, and R Frussa-Filho
January 1976, Advances in biochemical psychopharmacology,
C F Mello, and J Begnini, and D D De-La-Vega, and F P Lopes, and C C Schwartz, and R E Jimenez-Bernal, and R G Bellot, and R Frussa-Filho
September 1976, Bollettino della Societa italiana di biologia sperimentale,
C F Mello, and J Begnini, and D D De-La-Vega, and F P Lopes, and C C Schwartz, and R E Jimenez-Bernal, and R G Bellot, and R Frussa-Filho
October 1967, Die Naturwissenschaften,
C F Mello, and J Begnini, and D D De-La-Vega, and F P Lopes, and C C Schwartz, and R E Jimenez-Bernal, and R G Bellot, and R Frussa-Filho
January 1977, Methods in enzymology,
C F Mello, and J Begnini, and D D De-La-Vega, and F P Lopes, and C C Schwartz, and R E Jimenez-Bernal, and R G Bellot, and R Frussa-Filho
July 1955, The Journal of biological chemistry,
C F Mello, and J Begnini, and D D De-La-Vega, and F P Lopes, and C C Schwartz, and R E Jimenez-Bernal, and R G Bellot, and R Frussa-Filho
November 1994, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
C F Mello, and J Begnini, and D D De-La-Vega, and F P Lopes, and C C Schwartz, and R E Jimenez-Bernal, and R G Bellot, and R Frussa-Filho
January 1968, Progress in industrial microbiology,
C F Mello, and J Begnini, and D D De-La-Vega, and F P Lopes, and C C Schwartz, and R E Jimenez-Bernal, and R G Bellot, and R Frussa-Filho
July 1992, Seikagaku. The Journal of Japanese Biochemical Society,
C F Mello, and J Begnini, and D D De-La-Vega, and F P Lopes, and C C Schwartz, and R E Jimenez-Bernal, and R G Bellot, and R Frussa-Filho
January 1961, Postepy biochemii,
C F Mello, and J Begnini, and D D De-La-Vega, and F P Lopes, and C C Schwartz, and R E Jimenez-Bernal, and R G Bellot, and R Frussa-Filho
December 1973, Annals of the New York Academy of Sciences,
Copied contents to your clipboard!